Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Active symptom control may decrease chest pain, breathlessness, sweating, and
general discomfort in patients with malignant pleural mesothelioma. It is not yet known if
active symptom control is more effective with or without chemotherapy.
PURPOSE: This randomized phase III trial is studying active symptom control and chemotherapy
to see how well they work compared to active symptom control alone in treating patients with
malignant pleural mesothelioma.